ENDONOVO THERAPEUTICS, INC. Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, shares, new issues for the quarter ending 2023-09-30 was 1.00M shares.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, shares, new issues for the quarter ending 2021-12-31 was 5.83K shares.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, shares, new issues for fiscal 2021 was 2.51M shares.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, shares, new issues for fiscal 2014 was 11.71M shares, a 258.94% increase from fiscal 2013.
- ENDONOVO THERAPEUTICS, INC. stock issued during period, shares, new issues for fiscal 2013 was 3.26M shares.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2023-09-30 | 1.00M shares 10-Q · filed 2023-12-29 | |
| 2021-12-31 | 5.83K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | 2.51M shares 10-K · filed 2023-04-17 |
| 2014-12-31 | 11.71M shares 10-K · filed 2015-06-15 | |
| 2013-12-31 | 3.26M shares 10-K · filed 2015-06-15 |